Grand Biotek Inc.: 2026 Q1 EPS NT$-0.36

March 1, 2026

Key facts

Grand Biotek Inc.: 2026 Q1 EPS NT$-0.36
Grand Biotek Inc. announced its financial results for the first quarter of 2026, reporting a basic EPS of NT$-0.36, operating revenue of NT$6 million, and net loss after tax of NT$23 million. This indicates the company is operating at a loss.
Source: PR Times
Date: March 1, 2026

Direct answer

Grand Biotek Inc. announced its financial results for the first quarter of 2026, reporting a basic EPS of NT$-0.36, operating revenue of NT$6 million, and net loss after tax of NT$23 million. This indicates the company is operating at a loss.

Citation: Grand Biotek Inc.: 2026 Q1 EPS NT$-0.36 (March 1, 2026), PR Times
Source: PR Times
Date: March 1, 2026

Grand Biotek Inc. announced its financial results for the first quarter of 2026, reporting a basic EPS of NT$-0.36, operating revenue of NT$6 million, and net loss after tax of NT$23 million. This indicates the company is operating at a loss.

その他NQ 0/100出典：PR Times

📋 Article Processing Timeline

📰 Published: March 1, 2026 at 09:00
🔍 Collected: May 12, 2026 at 08:00 (1727h 0m after Published)
🤖 AI Analyzed: May 12, 2026 at 08:24 (23 min after Collected)

Company Code: 6794
Company Name: Grand Biotek Inc.
Industry: Biotechnology and Medical Industry
Period: 2026 Q1
Basic Earnings Per Share (EPS): NT$-0.36
Operating Revenue: NT$6 million
Net Profit After Tax: NT$-23 million

FAQ

What are the key facts in this article?

What is the direct answer?

What is the source and date?

PR Times: https://openapi.twse.com.tw/financial/twse-fin-6794-2026Q1 | March 1, 2026

Back to Newsroom (13)